LINA-DKD-5 10'S

About

LINA-DKD-5 likely refers to Linagliptin 5mg, a dipeptidyl peptidase-4 (DPP-4) inhibitor used for the treatment of type 2 diabetes mellitus. Linagliptin works by increasing the levels of active incretin hormones (GLP-1 and GIP), which are crucial for glucose homeostasis. These hormones stimulate insulin release from pancreatic beta cells and suppress glucagon secretion from alpha cells in a glucose-dependent manner, thereby lowering blood glucose. A significant advantage of linagliptin, particularly relevant to the 'DKD' (Diabetic Kidney Disease) in its name, is its primary excretion via the enterohepatic system. This means that no dose adjustment is required for patients with any degree of renal impairment, making it a highly suitable option for individuals with type 2 diabetes and co-existing kidney conditions, offering effective glycemic control without adding renal burden.

Uses

• Management of type 2 diabetes mellitus
• Improvement of glycemic control
• Adjunct to diet and exercise
• Suitable for patients with renal impairment

Directions For Use

Take orally once daily, with or without food, as directed by your physician. Swallow the tablet whole.

Benefits

• Effective in lowering blood glucose levels
• No dose adjustment needed for renal impairment
• Low risk of hypoglycemia (when used as monotherapy)
• Weight neutral effect
• Well-tolerated with a favorable safety profile
• Convenient once-daily dosing

Side Effects

• Nasopharyngitis
• Cough
• Diarrhea
• Headache
• Pancreatitis (rare)
• Severe allergic reactions (rare)
• Joint pain
• Muscle pain
• Skin rash
• Bullous pemphigoid (rare)
• Hypersensitivity reactions
• Constipation

Safety Measures

• Alcohol - No specific direct interaction, but excessive alcohol consumption can affect blood sugar levels and should be discussed with your doctor.
• Pregnancy - Not recommended during pregnancy. Consult your doctor if you are pregnant or planning to become pregnant.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if linagliptin passes into breast milk. Consult your doctor.
• Liver - Use with caution in patients with severe hepatic impairment, although no specific dose adjustment is typically needed.
• Kidney - No dose adjustment is required for any degree of renal impairment, making it a preferred option for patients with kidney conditions.
• Lung - No specific direct lung contraindication.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.